OncoStem
OncoStem
Claim
OncoStem develops innovative prognostic tests that assess the aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. OncoStem’s vision is to empower doctors with evidence-based treatment plans with their smart prognostic tests. These actionable tests help physicians formulate a customized treatment plan by understanding tumour biology.OncoStem develops innovative prognostic tests that assess the aggressiveness of tumours based on in- Show More
Alpha Score
$ 9.00 M
Alpha Score
57.0
Predictions
Overview
Team
Financials- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0